Home About Us Pipeline News Investors Contacts Careers


Puma Biotechnology, Inc. Corporate Fact Sheet


NEWS

EVENTS

CONTACT


June 27, 2016 - Puma Biotechnology Submits Marketing Authorization Application for PB272 (Neratinib) as Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer in Europe
Read

June 5, 2016 - Puma Biotechnology Presents Positive Phase II Data at the 2016 ASCO Annual Meeting
Read

May 18, 2016 - Puma Biotechnology Announces Publication of Neratinib Abstract for the 2016 ASCO Annual Meeting
Read

May 17, 2016 - Puma Biotechnology to Present at UBS Global Healthcare Conference
Read

May 10, 2016 - Puma Biotechnology Reports First Quarter 2016 Financial Results
Read

May 4, 2016 - Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference
Read


  • June 13, 2016 - Annual Meeting of Stockholders
    More

Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax
info@pumabiotechnology.com


Puma Biotechnology 2015 Annual Report

 Annual Report Archives